Argenx
ARGX
#540
Rank
$36.37 B
Marketcap
$595.70
Share price
-1.60%
Change (1 day)
58.32%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company